In a filing, Phio Pharmaceuticals Corp revealed its Chairman, Pres & CEO Bitterman Robert J acquired Company’s shares for reported $4840.0 on Jun 10 ’25. In the deal valued at $2.42 per share,2,000 shares were bought. As a result of this transaction, Bitterman Robert J now holds 27,149 shares worth roughly $67329.52.
Then, Ferrara Robert L bought 2,500 shares, generating $6,050 in total proceeds. Upon buying the shares at $2.42, the Director now owns 15,666 shares.
Before that, Bitterman Robert J bought 1,500 shares. Phio Pharmaceuticals Corp shares valued at $4,125 were divested by the Chairman, Pres & CEO at a price of $2.75 per share. As a result of the transaction, Bitterman Robert J now holds 25,149 shares, worth roughly $62369.52.
A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early August with a ‘”a Buy”‘ rating.
Price Performance Review of PHIO
On Tuesday, Phio Pharmaceuticals Corp [NASDAQ:PHIO] saw its stock jump 5.53% to $2.48. Over the last five days, the stock has gained 12.22%. Phio Pharmaceuticals Corp shares have fallen nearly -60.02% since the year began. Nevertheless, the stocks have risen 37.78% over the past one year. While a 52-week high of $9.79 was reached on 01/13/25, a 52-week low of $0.97 was recorded on 04/08/25.
Levels Of Support And Resistance For PHIO Stock
The 24-hour chart illustrates a support level at 2.35, which if violated will result in even more drops to 2.21. On the upside, there is a resistance level at 2.57. A further resistance level may holdings at 2.66.
How much short interest is there in Phio Pharmaceuticals Corp?
A steep rise in short interest was recorded in Phio Pharmaceuticals Corp stocks on 2025-06-13, dropping by -0.17 million shares to a total of 0.24 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 0.41 million shares. There was a decline of -71.42%, which implies that there is a negative sentiment for the stock.
